OR Royalties Q2 2026 Earnings: Worst Modest EPS Beat
OR Royalties Q2 2026 earnings report shows a modest EPS beat that fails to lift the shares, raising concerns among investors.
Top scooters 2026: Best picks for smart riders
Top scooters 2026 offers the best choices for riders looking for quality and style.
Understanding the Role of Pain Education in Surgical Recovery
Patient — Understanding the Role of Pain Education in Surgical Recovery
Om Galaxy IPO Allotment: Quick Guide to Your Status
Om Galaxy IPO allotment is crucial for investors. Check your status and subscription data now!
Gujarat Themis Biosyn revenue: Proven growth with 17% rise
Gujarat Themis Biosyn revenue sees a 17% increase, reaching Rs 44.23 cr in Q4, showcasing strong financial performance.
Exploring Innovative Endovascular Strategies for Critical Limb Ischemia
Explore innovative mapping strategies for treating critical limb ischemia and addressing complex arterial blockages.
Is Food Inflation in India the Worst Economic Challenge?
Food inflation India is rising rapidly, posing serious economic challenges for consumers and businesses alike.
Prasol Chemicals IPO: Best Quick Allotment Status Guide
Prasol Chemicals IPO status is now available. Check your allotment status easily via KFin Technologies, BSE, and NSE.
XRP ETFs: Is This the Best Time to Buy at $1.36?
XRP ETFs are gaining traction, holding 1.7% of all XRP. Is now the right time to invest at $1.36?
India IPO boom: Is it the best time for investors?
India IPO boom shows a record six offerings seeking US$480m in subscriptions.